Compounds > evans blue
Page last updated: 2024-08-21

evans blue and Retinopathy of Prematurity

evans blue has been researched along with Retinopathy of Prematurity in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bai, Y; Han, N; Huang, L; Li, X; Wang, F; Yu, W; Zhao, M; Zhou, A1

Other Studies

1 other study(ies) available for evans blue and Retinopathy of Prematurity

ArticleYear
Anti-angiogenic effect of KH902 on retinal neovascularization.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2013, Volume: 251, Issue:9

    Topics: Angiogenesis Inhibitors; Animals; Animals, Newborn; Apoptosis; Blotting, Western; Capillary Permeability; Cell Movement; Cell Proliferation; Dextrans; Disease Models, Animal; Dose-Response Relationship, Drug; Evans Blue; Flow Cytometry; Fluorescein Angiography; Fluorescein-5-isothiocyanate; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Inbred C57BL; Oxygen; Recombinant Fusion Proteins; Retinal Neovascularization; Retinal Vessels; Retinopathy of Prematurity; Vascular Endothelial Growth Factor A

2013